Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (91-100 of 354) with videos related to

Pageof 36
Sort By:
British Journal of Haematology|January 8, 2011
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocolsRachael F Grace, Suzanne E Dahlberg, Donna Neuberg, et al.
Cell|October 16, 2012
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AMLThanh-Trang Vo, Jeremy Ryan, Ruben Carrasco, et al.
British Journal of Haematology|October 22, 2016
Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observationMariela Sivina, Lillian Werner, Laura Rassenti, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapyAkila N Viswanathan, Holcombe E Grier, Heather J Litman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patientsRebecca Suk, Sarada Gurubhagavatula, Sohee Park, et al.
British Journal of Haematology|April 29, 2006
Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemiaThomas Pabst, Erica Stillner, Donna Neuberg, et al.
Oncotarget|October 6, 2017
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogrammingHaymanti Bhanot, Ellen L Weisberg, Mamatha M Reddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-upRonald C Chen, Michael S Chin, Andrea K Ng, et al.
Plos One|March 17, 2011
MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cellsShuqiang Li, Howell F Moffett, Jun Lu, et al.
Leukemia Research|February 14, 2014
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemiaDaniel J Deangelo, Donna Neuberg, Philip C Amrein, et al.
Pageof 36

Showing results (91-100 of 354) with videos related to

Sort By:
Pageof 36
British Journal of Haematology|January 8, 2011
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocolsRachael F Grace, Suzanne E Dahlberg, Donna Neuberg, et al.
Cell|October 16, 2012
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AMLThanh-Trang Vo, Jeremy Ryan, Ruben Carrasco, et al.
British Journal of Haematology|October 22, 2016
Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observationMariela Sivina, Lillian Werner, Laura Rassenti, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapyAkila N Viswanathan, Holcombe E Grier, Heather J Litman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patientsRebecca Suk, Sarada Gurubhagavatula, Sohee Park, et al.
British Journal of Haematology|April 29, 2006
Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemiaThomas Pabst, Erica Stillner, Donna Neuberg, et al.
Oncotarget|October 6, 2017
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogrammingHaymanti Bhanot, Ellen L Weisberg, Mamatha M Reddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-upRonald C Chen, Michael S Chin, Andrea K Ng, et al.
Plos One|March 17, 2011
MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cellsShuqiang Li, Howell F Moffett, Jun Lu, et al.
Leukemia Research|February 14, 2014
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemiaDaniel J Deangelo, Donna Neuberg, Philip C Amrein, et al.
Pageof 36